| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Beryl Capital Management LLC reports a 0% stake in LogicBio Therapeutics, Inc. |
| 02/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/29/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 11/21/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/17/2022 |
4
| Kay Mark A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 784,557 shares
@ $0
Disposed/sold 140,615 options to buy
@ $0.73, valued at
$102.6k
Disposed/sold 13,089 options to buy
@ $0.73, valued at
$9.6k
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Enyedy Mark J (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 2,921 shares
@ $0
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Nacht Mariana (Chief Scientific Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $0.7, valued at
$70k
|
|
| 11/17/2022 |
4
| WYZGA MICHAEL S (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 3,141 shares
@ $0
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Chereau Frederic (President, CEO) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 253,811 shares
@ $0
Disposed/sold 547,000 options to buy
@ $0.73, valued at
$399.3k
Disposed/sold 328,000 options to buy
@ $0.7, valued at
$229.6k
|
|
| 11/17/2022 |
4
| MOSCICKI RICHARD A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 3,916 shares
@ $0
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Goater Jeff (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Karydas Daphne (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Chen Leon (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 22,333 shares
@ $0
Disposed/sold 44,508 options to buy
@ $0.73, valued at
$32.5k
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Gruskin Daniel (Chief Medical Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 3,331 shares
@ $0
Disposed/sold 140,000 options to buy
@ $0.7, valued at
$98k
|
|
| 11/17/2022 |
4
| Kahn Susan (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/16/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/16/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/16/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/16/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/16/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/16/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 11/16/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/16/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/16/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/20/2022 |
8-K
| Quarterly results |
| 10/20/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/18/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/18/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/13/2022 |
SC 13G
| Beryl Capital Management LLC reports a 9.9% stake in LogicBio Therapeutics, Inc. |
| 10/07/2022 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 10/03/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/03/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 10/03/2022 |
8-K
| Quarterly results |
| 09/30/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|